Simplex Trading’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Simplex Trading’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-770	Closed	-$15.6K	–	10118
2026 Q1	$15.6K	Sell	770 -66	-8%	-$13.2K	﹤0.01%	6966
2025 Q4	$560K	Buy	836 +393	+89%	+$198K	﹤0.01%	3190
2025 Q3	$144K	Buy	+443	New	+$148K	﹤0.01%	5331
2024 Q3	–	Sell	-11	Closed	-$1.58K	–	9360
2024 Q2	$1K	Sell	11 -13	-54%	-$2.35K	﹤0.01%	8541
2024 Q1	$4K	Buy	24 +21	+700%	+$5.22K	﹤0.01%	8150
2023 Q4	$0	Buy	+3	New	+$601	﹤0.01%	9623
2023 Q1	–	Sell	-332	Closed	-$65K	–	9917
2022 Q4	$42K	Buy	332 +49	+17%	+$8.19K	﹤0.01%	6086
2022 Q3	$75K	Sell	283 -7	-2%	-$2.67K	﹤0.01%	5900
2022 Q2	$128K	Buy	+290	New	+$205K	﹤0.01%	5227
2020 Q4	–	Sell	-6	Closed	-$53.2K	–	8917
2020 Q3	$63K	Buy	+6	New	+$54.6K	﹤0.01%	5389

Other funds holding IRLA

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Simplex Trading's IRLA Position: Q2 2026 in Review

Simplex Trading sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2026, closing a stake of 770 shares — an estimated $15.6K sold.

Simplex Trading first reported a position in IRLA in Q3 2020 and held it in 10 quarters. The position peaked at $560K in Q4 2025. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

Simplex Trading reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 770 IRulya Therapeutics Inc. Common Stock shares in Q2 2026, an estimated $15.6K.
Simplex Trading first reported a position in IRulya Therapeutics Inc. Common Stock in Q3 2020 and held it in 10 quarters.
Simplex Trading's IRulya Therapeutics Inc. Common Stock position peaked at $560K in Q4 2025.
26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.